Sadia Rahman
Stock Analyst at Wells Fargo
(2.98)
# 2,656
Out of 4,598 analysts
12
Total ratings
60%
Success rate
13.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sadia Rahman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDGL Madrigal Pharmaceuticals | Initiated Coverage: Buy | $685 | $482.00 | +42.12% | 1 | Jul 27, 2026 | |
| DNTH Dianthus Therapeutics | Rated: Buy | $135 | $106.02 | +27.33% | 5 | Jun 17, 2026 | |
| VOR Vor Biopharma | Reiterated: Buy | $30 | $21.41 | +40.12% | 3 | May 13, 2026 | |
| MAZE Maze Therapeutics | Maintained: Buy | $55 | $27.33 | +101.24% | 3 | May 13, 2026 |
Madrigal Pharmaceuticals
Jul 27, 2026
Initiated Coverage: Buy
Price Target: $685
Current: $482.00
Upside: +42.12%
Dianthus Therapeutics
Jun 17, 2026
Rated: Buy
Price Target: $135
Current: $106.02
Upside: +27.33%
Vor Biopharma
May 13, 2026
Reiterated: Buy
Price Target: $30
Current: $21.41
Upside: +40.12%
Maze Therapeutics
May 13, 2026
Maintained: Buy
Price Target: $55
Current: $27.33
Upside: +101.24%